PD-L1 expression in tumor cells can either be driven by cell-intrinsic mechanisms or by a process termed adaptive resistance, through interferon-γ signaling and subsequent activation of STAT transcription factors, which we also see induced by AZA (Fig. 1E). This evidence concerns the gene CD274 and neoplasm.